CelLBxHealth plc (ANPCF)
OTCMKTS · Delayed Price · Currency is USD
0.0168
-0.0029 (-14.72%)
At close: Nov 25, 2025
CelLBxHealth Revenue
CelLBxHealth had revenue of 796.00K GBP in the half year ending June 30, 2025, a decrease of -33.44%. This brings the company's revenue in the last twelve months to 2.62M, up 29.64% year-over-year. In the year 2024, CelLBxHealth had annual revenue of 2.86M with 30.92% growth.
Revenue (ttm)
2.62M GBP
Revenue Growth
+29.64%
P/S Ratio
4.52
Revenue / Employee
22.05K GBP
Employees
119
Market Cap
16.25M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.86M | 676.00K | 30.92% |
| Dec 31, 2023 | 2.19M | 1.15M | 109.99% |
| Dec 31, 2022 | 1.04M | 28.00K | 2.76% |
| Dec 31, 2021 | 1.01M | 251.00K | 32.94% |
| Dec 31, 2020 | 762.00K | -109.50K | -12.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global Cord Blood | 196.10M |
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Interpace Biosciences | 41.92M |
| Psychemedics | 19.69M |
| China New Energy Group Company | 12.51M |
| Aspira Women's Health | 9.34M |
| Longduoduo Company | 2.72M |
CelLBxHealth News
- 2 months ago - CelLBxHealth plc (ANPCY) Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation Transcript - Seeking Alpha
- 3 months ago - CelLBxHealth PLC Presents Proof-of-Concept Study - Accesswire
- 3 months ago - Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding - Accesswire
- 3 months ago - AIM Market Roundup: Angle, Coyngar, Light Science Technologies - The Armchair Trader
- 4 months ago - ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor - Accesswire
- 4 months ago - Angle PLC Announces Strategy Update - Accesswire
- 4 months ago - Angle PLC Announces Presentation of Data on Glioblastoma - Accesswire
- 5 months ago - Angle PLC Announces Board Changes - Accesswire